Michael A. Martino - Nov 22, 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc. (AMPE)

Role
INTERIM CHAIRMAN AND CEO, Director
Signature
/s/ Dan Stokely, Attorney-in-Fact
Stock symbol
AMPE
Transactions as of
Nov 22, 2021
Transactions value $
$0
Form type
4
Date filed
11/24/2021, 03:50 PM
Previous filing
Oct 25, 2021
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +750K $0.00 750K Nov 22, 2021 Common Stock 750K $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested and became exercisable with respect to 500,000 shares of common stock on November 22, 2021, and will vest with respect to the remaining 250,000 shares of common stock on November 22, 2022.